Kamada Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0010941198
ILS
23.02
0.2 (0.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kamada Ltd.
Why is Kamada Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.54%
  • Poor long term growth as Net Sales has grown by an annual rate of 5.96% and Operating profit at 5.59% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
With ROE of 10.49%, it has a Expensive valuation with a 1.46 Price to Book Value
  • Over the past year, while the stock has generated a return of 7.42%, its profits have risen by 41.3% ; the PEG ratio of the company is 0.3
3
Underperformed the market in the last 1 year
  • The stock has generated a return of 7.42% in the last 1 year, much lower than market (Israel TA-100) returns of 48.91%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kamada Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kamada Ltd.
7.42%
0.84
27.64%
Israel TA-100
48.91%
2.91
16.81%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
5.96%
EBIT Growth (5y)
5.59%
EBIT to Interest (avg)
22.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.64
Tax Ratio
7.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.84%
ROCE (avg)
9.54%
ROE (avg)
4.99%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.46
EV to EBIT
11.25
EV to EBITDA
7.17
EV to Capital Employed
1.61
EV to Sales
1.71
PEG Ratio
0.34
Dividend Yield
0.04%
ROCE (Latest)
14.28%
ROE (Latest)
10.49%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend